Q Pula Trading Management LP Vertex Pharmaceuticals Inc Transaction History

Q Pula Trading Management LP

  • $289 Million
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$221.42 - $260.97 $467,196 - $550,646
-2,110 Closed
0 $0
Q4 2021

Feb 08, 2022
SELL
$177.01 - $223.45 $229,050 - $289,144
-1,294 Closed
0 $0
Q3 2021

Nov 09, 2021
BUY
$181.39 - $202.99 $234,718 - $262,669
1,294 New
1,294 $235,000

Others Institutions Holding VRTX

# of Institutions
1,723
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Q Pula Trading Management LP Portfolio

Follow Q Pula Trading Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Q Pula Trading Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Q Pula Trading Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email